Department of Emergency Medicine, Columbia University Medical Center, New York, NY, United States.
Department of Pediatrics, Division of Hematology/Oncology/Stem Cell Transplantation, Columbia University Medical Center, New York, NY, United States.
Complement Ther Med. 2020 Mar;49:102314. doi: 10.1016/j.ctim.2020.102314. Epub 2020 Jan 10.
To describe the use of acupuncture for pain management in children with sickle cell disease.
A retrospective chart review of a single-institution experience on the use of acupuncture in pediatric patients with sickle cell disease was evaluated between 2012-2019. Demographic characteristics, presenting pain location, pain scores pre- and post-acupuncture, and adverse events were collected.
Columbia University Medical Center, NewYork-Presbyterian Morgan Stanley Children's Hospital Pediatric Hematology outpatient and inpatient units.
Acupuncture was performed by six licensed acupuncturists. Point prescriptions were based on pain location, philosophies of Traditional Chinese Medicine and Japanese Style of Kiiko Matsumoto acupuncture.
Pain reduction as measured by two Verbal Pain Scales.
Ninety acupuncture treatments were administered to twenty-four patients with sickle cell disease: median age 17.5 years, 62 % female, 37.5 % African American, 50 % Hispanic. The mean treatment duration was 18.5 ± 4.8 min. Fifty-five treatments had documented pre/post-acupuncture pain scores. Pain reduction was achieved in 65.5 % of these treatments. A 0-10 pain scale used in 13 treatments reported a mean pre-acupuncture score of 7.31 ± 1.75, post-acupuncture score of 6.08 ± 1.85, and a mean pain score change of 1.23 ± 1.09 (p = 0.11); A 0-4 pain scale used in 42 treatments reported a mean pre-acupuncture pain score of 3.31 ± 0.72, post-acupuncture score of 2.33 ± 0.98, and a mean pain score change of 0.98 ± 0.99 (p < 0.0001). No adverse events were noted.
Acupuncture therapy decreased pain for our patients with sickle cell disease, providing a safe non-opioid therapeutic option.
描述针刺疗法在镰状细胞病患儿疼痛管理中的应用。
对 2012 年至 2019 年间哥伦比亚大学医学中心纽约长老会摩根士丹利儿童医院儿科血液门诊和住院病房使用针刺治疗镰状细胞病患儿的单机构经验进行回顾性图表审查。收集人口统计学特征、疼痛发生部位、针刺前后疼痛评分和不良事件。
哥伦比亚大学医学中心，纽约长老会摩根士丹利儿童医院儿科血液门诊和住院病房。
由六名持照针灸师进行针刺治疗。针刺处方基于疼痛部位、中医和日本 Kiiko Matsumoto 针灸的哲学。
采用两种语言疼痛量表测量疼痛缓解程度。
共对 24 例镰状细胞病患儿进行了 90 次针刺治疗：中位年龄 17.5 岁，62%为女性，37.5%为非裔美国人，50%为西班牙裔。平均治疗时间为 18.5±4.8 分钟。55 次治疗记录了针刺前后的疼痛评分。这些治疗中有 65.5%达到了疼痛缓解。在 13 次治疗中使用的 0-10 疼痛量表报告的平均针刺前疼痛评分为 7.31±1.75，针刺后疼痛评分为 6.08±1.85，平均疼痛评分变化为 1.23±1.09（p=0.11）；在 42 次治疗中使用的 0-4 疼痛量表报告的平均针刺前疼痛评分为 3.31±0.72，针刺后疼痛评分为 2.33±0.98，平均疼痛评分变化为 0.98±0.99（p<0.0001）。未观察到不良事件。
针刺疗法可减轻镰状细胞病患儿的疼痛，为非阿片类药物治疗提供了一种安全的选择。
